Pharmacoeconomic Promotion May Change Less Than Expected - Perfetto
Executive Summary
The healthcare economic claim provisions of the FDA Modernization Act may not change the pharmacoeconomic promotion environment as much as had initially been anticipated, QualityMetric Exec VP Eleanor Perfetto, PhD, reported to a Pharmaceutical Education and Research Institute meeting in Baltimore, Md. Sept. 30.